Ambisome
Product Images NDC 0469-3051

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Ambisome (NDC 0469-3051). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Astellas Pharma Us, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Description (Image 01)

Cross section view of a liposome illustrating the phospholipid bilayer and embedded amphotericin B molecules. The diagram highlights the structural arrangement within the liposome.*

FDA Label Image

Structure (Image 02)

Chemical structure of the active ingredient shown on the AmBisome product label, depicting a detailed molecular diagram with multiple hydroxyl groups and complex ring structures.*

FDA Label Image

Graph1 (Image 03)

Line graph titled 'Mean Change in Creatinine Over Time in Study 94-0-002' showing mean change in creatinine levels (mg/dL) over weeks on study for two treatments. The treatments compared are AmBisome 3 mg/kg/day and Amphotericin B 0.6 mg/kg/day, with AmBisome represented by a line with triangle markers and Amphotericin B by a line with square markers. The graph covers 0 to 4 weeks with creatinine changes rising more steeply for Amphotericin B compared to AmBisome.*

FDA Label Image

Graph2 (Image 04)

A line graph titled "Mean Creatinine Concentrations Over Time" showing mean creatinine concentration measured in mg/dL on the vertical axis and day of test on the horizontal axis. Two data series are plotted: one for patients whose pretreatment value was greater than 1.7 mg/dL (blue diamonds) and one for all episodes (pink squares), with sample sizes indicated at various points.*

FDA Label Image

Ambisome (amphotericin B) Liposome For Injection Label (Image 05)

AmBisome (amphotericin B) liposome for injection 50 mg single-use vial packaging label from Astellas Pharma US, Inc. The label includes drug contents, storage instructions at up to 25°C, and a warning that AmBisome is not interchangeable on a mg per mg basis with other amphotericin B products. The label also features manufacturer information, a barcode, and Gilead and Astellas logos.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.